Roberta Pepa-Della

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

Journal: British journal of haematology

Published: April 26, 2026

Deep and durable response with the selinexor-bortezomib-dexamethasone combination in a patient with multiple myeloma refractory to first-line treatment

Deep and durable response with the selinexor-bortezomib-dexamethasone combination in a patient with multiple myeloma refractory to first-line treatment

Journal: Recenti progressi in medicina

Published: February 20, 2026

Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.

Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.

Journal: Blood advances

Published: February 05, 2026

Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses.

Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses.

Journal: Blood advances

Published: February 05, 2026

Thrombin generation profiling in multiple myeloma: a comprehensive evaluation of prothrombotic state.

Thrombin generation profiling in multiple myeloma: a comprehensive evaluation of prothrombotic state.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Published: January 26, 2026

Peripherally inserted central venous catheters for remission induction chemotherapy phase of acute leukemia: a single center experience in severely thrombocytopenic patients.

Peripherally inserted central venous catheters for remission induction chemotherapy phase of acute leukemia: a single center experience in severely thrombocytopenic patients.

Journal: Annals of hematology

Published: January 14, 2026

Thrombotic complications of central venous catheterization with peripherally inserted catheters in patients with classical-Hodgkin lymphoma.

Thrombotic complications of central venous catheterization with peripherally inserted catheters in patients with classical-Hodgkin lymphoma.

Journal: HemaSphere

Published: October 19, 2025

Recurrent cytokine release syndrome in patients receiving bispecific antibody therapy for multiple myeloma: a case series.

Recurrent cytokine release syndrome in patients receiving bispecific antibody therapy for multiple myeloma: a case series.

Journal: Annals of hematology

Published: October 03, 2025

Refining the role of selinexor in multiple myeloma: strategic use in a shifting treatment landscape.

Refining the role of selinexor in multiple myeloma: strategic use in a shifting treatment landscape.

Journal: ESMO open

Published: July 11, 2025

Correction: Sgherza et al. Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study. Pharmaceuticals 2025, 18, 595.

Correction: Sgherza et al. Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study. Pharmaceuticals 2025, 18, 595.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 27, 2025

Impact of Dara-VTD induction therapy on stem cell mobilization outcomes in newly diagnosed multiple myeloma patients undergoing autologous stem cell transplantation: a multicenter study.

Impact of Dara-VTD induction therapy on stem cell mobilization outcomes in newly diagnosed multiple myeloma patients undergoing autologous stem cell transplantation: a multicenter study.

Journal: Annals of hematology

Published: April 24, 2025

An Italian real-world multicenter study of patients with refractory/relapsed functional high-risk multiple myeloma patients treated with second-line therapies.

An Italian real-world multicenter study of patients with refractory/relapsed functional high-risk multiple myeloma patients treated with second-line therapies.

Journal: Annals of hematology

Published: April 18, 2025

Showing 1-12 of 62

Last Updated: 09/26/2026